2 line items for rituximab vials. Awarded for a base year of 9/15/2020 to 9/14/2021 plus 4 one-year option periods.

Ended Indefinite Delivery Contract Awarded Last action

Contract number
36E79720D0052
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 100% complete
IDV ceiling
$83,732,812.80
Award type
Single award
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

This Indefinite Delivery Contract (IDC) was awarded by the National Acquisition Center, a civilian agency of the U.S. federal government, to Pfizer Inc. as the prime contractor. The contract has a total ceiling value of $83,732,812.80 and a period of performance from September 15, 2020 to September 14, 2025, including a base year and four one-year option periods.

The purpose of this IDC is to procure rituximab vials for the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. The contract covers an estimated annual requirement of 21,788 vials of 100mg rituximab and 26,793 vials of 500mg rituximab. Pfizer, a large pharmaceutical manufacturer, will be the sole provider of these critical medical products to support government healthcare initiatives across multiple federal agencies. This IDC demonstrates Pfizer's significant role in supplying pharmaceuticals and vaccines to the U.S. federal government, including through other major Indefinite Delivery Vehicles such as a $7.31 billion Federal Supply Schedule contract with the Department of Veterans Affairs.

Transactions

Action Obligated Date
Add Subcontract Plan P00017 · Adding 2025 subcontracting plan for pfizer, INC. $0
Other Administrative Action P00016 · 2025 public law updates $0
Exercise an Option P00015 · Exercise 4TH and final option year. $0
Supplemental Agreement for work within scope P00014 · Cost recovery fee change MOD $0
Add Subcontract Plan P00013 · 2024 subcontracting plan $0
Other Administrative Action P00012 · 2024 public law pricing updates $0
Exercise an Option P00011 · Excersise 3RD option year for contract 36E79720D0052 with pfizer INC $0
Other Administrative Action P00010 · Incorporate dscsa language $0
Add Subcontract Plan P00009 · 2023 subcontracting plan $0
Other Administrative Action P00008 · 2023 federal ceiling price - national contracts for contract 36E79720D0052 with pfizer, INC. With no change in national contract prices. $0
Exercise an Option P00007 · Modification to exercise option year 2 for contract 36E79720D0052 with pfizer, INC. With no change in national contract prices. $0
Add Subcontract Plan P00006 · Incorporate 2022 subk plan. No change in national contract prices. $0
Other Administrative Action P00005 · Incorporate 2022 federal ceiling prices. No change in national contract prices. $0
Exercise an Option P00004 · Exercising option year 1 for contract 36E79720D0052 with no price changes. $0
Other Administrative Action P00003 · Administrative POC change $0
Add Subcontract Plan P00002 · Incorporate 2021 subcontracting plan $0
Other Administrative Action P00001 · The awarded national contract prices under the contract remain below the fcps for 2021. $0
Original award $0
Show all 18

Quick answers

Who was awarded contract 36E79720D0052?

36E79720D0052 was awarded to Pfizer Inc. by National Acquisition Center (Headquarters) on September 15, 2020.

How much is contract 36E79720D0052 worth?

36E79720D0052's own ceiling is $83,732,813.

Who can order from contract 36E79720D0052?

36E79720D0052 is a single award indefinite delivery contract.

Was contract 36E79720D0052 competed?

The extent of competition for 36E79720D0052 was full and open competition. The government received 3 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV